PreveCol® is an innovative blood-based test for the early detection of colorectal cancer (CRC) or advanced adenomas (AA) and precancerous lesions. It is based on an algorithm that combines the clinical characteristics with the analysis of biomarker levels present in blood.
Análisis clínicos, Digestivos, Oncológicos, Tipos de análisis
PreveCol®
450,00 €
What does it include?
- VIDEO CONSULTATION: 2 video consultations with a specialist physician (the 1st for the request of the test and the 2nd for the delivering and interpretation of the results).
- EXTRACTION of the blood sample in the centre closest to you.
- PreveCol® RESULTS REPORT
What does it include?
- VIDEO CONSULTATION: 2 video consultations with a specialist physician (the 1st for the request of the test and the 2nd for the delivering and interpretation of the results).
- EXTRACTION of the blood sample in the centre closest to you.
- PreveCol® RESULTS REPORT
More information
PreveCol® is indicated for asymptomatic men and women, aged between 50 and 75 years old, who are at an average risk of developing colorectal cancer.
